Researchers from the University of Medicine and Pharmacy in Vietnam and University of Adelaide in Australia showed that ongoing pregnancy rates and live births were equivalent in a group of IVF women implanted with frozen embryos compared with fresh embryos.
"Frozen embryo techniques are growing in popularity in fertility clinics worldwide. This is one of the reasons why our research is important for fertility clinicians and researchers, and of course couples who are hoping to have a child," said Lan N Vuong from University of Medicine and Pharmacy in Vietnam.
Women were given one cycle of IVF, where either a transfer of fresh embryos occurred, or all embryos were frozen and one cycle of thawed embryos occurred subsequently without the use of IVF drugs.
After the first completed cycle of IVF, ongoing pregnancy occurred in 36 per cent of women in the frozen embryo group, and in 35 per cent of the fresh embryo group.
Rates of live birth after the first embryo transfer were 34 per cent in the frozen embryo group, and 32 per cent in the fresh embryo group.
"This new study shows that infertile women not suffering from PCOS have equivalent live IVF birth rates from frozen embryos, which is important news for infertile women worldwide," said Mol.
"Our key finding is that freezing embryos for IVF is not harming a couple's chances of having a baby. After the first fresh embryo transfer, it will be possible to freeze the remaining embryos and transfer them one by one, which is safe and effective," he said.
"Couples concerned about such unnecessary costs of freezing all embryos do not need to go down that path, and will still have the same live birth success rate," he said.
"Our research results are specific to a common freezing method known as Cryotech vitrification, so it may not apply to all embryo freezing techniques currently being used," said Vuong.
"Further research will be needed to compare pregnancy outcomes and live birth rates from other embryo freezing techniques," he said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
